Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00053261 · ClinicalTrials.gov registry record
Vaginal Changes and Sexual Function in Patients With Cervical Cancer
A clinical trial of Cervical Cancer and Sexuality and Reproductive Issues, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- 12
- Study locations
NCT00053261 is a study of Cervical Cancer and Sexuality and Reproductive Issues that has completed, run by Gynecologic Oncology Group. The trial reports 12 study locations across 7 states.
The verdict
NCT00053261, a study of Cervical Cancer and Sexuality and Reproductive Issues, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- 12
- Study locations
Study Summary
RATIONALE: Vaginal changes that may effect sexual function occur in patients undergoing treatment for cervical cancer. PURPOSE: Clinical trial to determine the type of vaginal changes such as vaginal dryness that occur in patients receiving treatment for cervical cancer and the effect these changes have on sexual function.
Conditions Studied
Interventions
- PROCEDURE management of therapy complications
Study Locations (12)
Michigan
- Bronson Methodist Hospital - Kalamazoo
- West Michigan Cancer Center - Kalamazoo
- Borgess Medical Center - Kalamazooaa
New York
- Long Island Cancer Center at Stony Brook University Hospital - Stony Brook
- SUNY Upstate Medical University Hospital - Syracuse
Oklahoma
- Oklahoma University Medical Center - Oklahoma City
- Cancer Care Associates - Midtown Tulsa - Tulsa
Pennsylvania
- Abington Memorial Hospital - Abington
- John and Dorothy Morgan Cancer Center at Lehigh Valley Hospital - Allentown
Georgia
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center - Savannah
Missouri
- Ellis Fischel Cancer Center at University of Missouri - Columbia - Columbia
North Carolina
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00053261
The ClinicalTrials.gov registry entry for NCT00053261 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which management of therapy complications is the first listed.
NCT00053261 reports 12 study locations spanning 7 distinct geographic areas - top geographies include Michigan, New York, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT00053261 about?
NCT00053261 is a clinical study titled "Vaginal Changes and Sexual Function in Patients With Cervical Cancer". RATIONALE: Vaginal changes that may effect sexual function occur in patients undergoing treatment for cervical cancer. PURPOSE: Clinical trial to determine the type of vaginal changes such as vaginal dryness that occur in patients receiving treatment for cervical cancer and the effect these changes...
What is the current status of trial NCT00053261?
This trial is currently completed. The study started on 2003-07.
What conditions does trial NCT00053261 study?
This clinical trial studies the following conditions: Cervical Cancer, Sexuality and Reproductive Issues.
What interventions are being tested in trial NCT00053261?
The interventions under investigation include: management of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00053261?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00053261 being conducted?
This trial has 12 study locations across Georgia, Michigan, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
RECRUITING
-
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
RECRUITING · Phase 2
-
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RECRUITING · Phase 2
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
PopSci CHW4CervixHealth
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.